DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual meeting filing with no surprises. Monitor for the outcome of the shareholder vote, but expect no immediate market impact.
Final — all horizons settled through T+60d
TRDA ▼ -48.85% at T+60d
NEUTRAL call ✗ call lost -48.85% · α vs SPY -53.93% · entry $12.63 → $6.46
T+1d
+2.61%
call +2.61% · α +2.45%
$12.96
settled 5mo ago
T+5d
+6.89%
call +6.89% · α +5.98%
$13.50
settled 5mo ago
T+20d
-50.04%
call -50.04% · α -54.07%
$6.31
settled 4mo ago
T+60d
-48.85%
call -48.85% · α -53.93%
$6.46
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Entrada Therapeutics is holding a shareholder meeting to vote on the election of directors, approval of the 2025 annual compensation program, and ratification of auditors. The filing is a definitive additional materials document, which is routine for an annual meeting.
Key Facts
- Filing is a Definitive Additional Materials (DEFA14A) for an annual shareholder meeting.
- Vote includes election of directors, approval of 2025 annual compensation program, and ratification of auditors.
- No activist campaign or dissident filing; this is a routine management filing.
- Recent insider activity shows minimal selling ($32K over 30 days).
Financial Impact
Minimal to no direct financial impact from this filing.
revenueepsdebtdilution
Risk Factors
- Potential shareholder dissent on executive compensation (though not indicated in this filing).
- Regulatory or compliance risk if auditors are not ratified.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001689375-26-000022 |
| Document: 0001689375-26-000022-index-headers.html | 0001689375-26-000022 |
| Document: 0001689375-26-000022-index.html | 0001689375-26-000022 |
| Document: 0001689375-26-000022.txt | 0001689375-26-000022 |
18 reports for TRDA
50% Hit rate best @ T+60▲ +58.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | Insider Cluster | $6.42 $6.90 | ▼ −7.48% | ▼ −7.98% | $5.38 (+16.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $7.17 $6.80 | ▼ −5.16% | ▼ −4.01% | $5.38 (−24.97%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 31, 2026 4w ago | Insider Cluster | $7.07 $7.11 | ▲ +0.57% | ▲ +0.48% | $5.38 (−23.90%) |
Aug 27, 2026 5w ago | Insider Cluster | $7.27 $7.17 | ▼ −1.38% | ▼ −1.64% | $5.38 (−26.00%) |
Aug 10, 2026 7w ago | Insider Cluster | $7.04 $7.27 | ▲ +3.27% | ▲ +3.67% | $5.38 (−23.58%) |
Aug 5, 2026 8w ago | 8-K | $7.06 $7.67 | ▲ +8.64% | ▲ +8.29% | $5.38 (−23.80%) |
Aug 3, 2026 8w ago | Insider Cluster | $7.24 $7.04 | ▼ −2.76% | ▼ −2.66% | $5.38 (−25.69%) |
Jul 30, 2026 9w ago | 144 | $6.79 $6.87 | ▼ −1.18% | ▲ +2.33% | $5.38 (+20.77%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (65h 4m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access